Clinical Trial Update: Subcutaneous Recombinant Human Hyaluronidase: Workflow Analysis and Emergency Department Design

View source ↗

Summary

A University of California, San Diego-sponsored clinical trial evaluating subcutaneous recombinant human hyaluronidase for dehydration has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dehydration

Drugs mentioned

• Hylenex recombinant human hyaluronidase (recombinant human hyaluronidase PH20)

Snippet

Sponsor: University of California, San Diego | Conditions: Dehydration | Status: WITHDRAWN